1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Survival Strategies for the Global In Vitro Diagnostics Industry

Survival Strategies for the Global In Vitro Diagnostics Industry

  • April 2014
  • -
  • Frost & Sullivan
  • -
  • 46 pages

Summary

Table of Contents

Slowing US and European Markets Demand Alignment with Global Market Needs

Executive Summary

- While there is a positive outlook for global in vitro diagnostics (IVD), top companies face challenges such as slowing growth, increasing competition, and a changing business environment.
- Prime opportunities include pursuing the underpenetrated Brazil, Russia, India, and China (BRIC) markets; and high-growth IVD segments, such as point-of-care testing (POCT) and self monitoring of blood glucose (SMBG).
- Beyond the BRIC countries, the African IVD market holds early-stage opportunities but the market differences should be understood.
- Due to cuts in reimbursement, clinical laboratories are becoming more open to new technologies that can reduce operating costs.
- An IVD company that leverages external partners for developing cost reducing technologies may have a competitive edge.

Industry Overview and Definitions

•IVD is a $x billion market worldwide and is growing in the mid single-digits. Market revenue consists of product sales of the instruments and consumables.
•IVD are tests that can detect disease, conditions, or infections in patients. Testing occurs outside of the body on specimens like blood, tissue, or urine.
•Customers of IVD products are typically hospitals and laboratories. Customer segmentation varies according to region.
•Much of the US IVD testing volume occurs in hospital laboratories.

Key Market Principles

•The unit in this market is test volume that comes from test utilization, which is most significantly impacted by healthcare access.
•There are improving valuations for diagnostics, which is evident in the companion diagnostics segment.
•There is strong demand for segments using advanced technology like molecular diagnostics and clinical sequencing.

Segment Trends

•IVD segments
oImmunochemistry
oPOCT
oSMBG
oMolecular diagnostics
oMicrobiology
oCoagulation
oHematology
oTissue diagnostics
•Key segment trends
oThe immunochemistry segment is the largest segment and is growing more rapidly than the others.
- In previous years, growth had been driven by volume since these are routine tests and this area of the laboratory is very automated. Presently and moving forward, this segment is more and more driven by growing demand from China and other emerging markets.
oThe molecular diagnostics segment also has an impressive growth trajectory. This segment may reach the size of the POCT segment within 3 years.

Intensifying Competitive Landscape

•Tier I Companies: Roche Diagnostics, Siemens Healthcare, Abbott Laboratories, Ortho Clinical Diagnostics (J&J), and Beckman Coulter (Danaher).
•Tier II Companies: Alere, Bayer Diabetes Care, bioMerieux, Sysmex, and Becton Dickinson.
•In the period 2009–2012, Tier I and Tier II have increased their market share at the expense of other weaker competitors. The pace of consolidation is remarkable and will only continue in these challenging market dynamics.
•Further consolidation is expected in the future with M&A guided by strengthening or gaining access to new regions and customer segments.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
2017 World Automated Microbiology Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Volume and Sales Forecasts for 100 Molecular Diagnostic Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Automated Microbiology Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Volume and Sales Forecasts for 100 Molecular Diagnostic Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 52500
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 75-country survey from VPGMarketResearch.com provides granular data and analysis not available from any other published source. The survey is designed to help current suppliers and potential market ...

2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

  • $ 47500
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides granular analysis of the Europe diagnostic testing market, including Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, ...

2017 Asia-Pacific Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2017 Asia-Pacific Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

  • $ 35000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides granular analysis of the Asia-Pacific diagnostic testing market, including Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.